52 - References

References

622 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 5 References

1. Gringras P. When to use drugs to help sleep. Arch Dis Child 2008; 93:­976–­981.
2. Macchi MM, et al. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol 2004; 25:­177–­195.
3. Gringras P, et al. Efficacy and safety of pediatric prolonged-­release melatonin for insomnia in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 2017; 56:­948–­957.e944.
4. Williams Buckley A, et al. Practice guideline: treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2020; 94:­392–­404.
5. Xiong M, et al. Efficacy of melatonin for insomnia in children with autism spectrum disorder: a meta-­analysis. Neuropediatrics 2023; 54:­167–­173.
6. Van der Heijden KB, et al. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-­onset insomnia. J Am Acad Child Adolesc Psychiatry 2007; 46:­233–­241.
7. Weiss MD, et al. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 2006; 45:­512–­519.
8. Edemann-­Callesen H, et al. Use of melatonin for children and adolescents with chronic insomnia attributable to disorders beyond indication: a systematic review, meta-­analysis and clinical recommendation. EClinicalMedicine 2023; 61:102049.
9. Ferracioli-­Oda E, et al. Meta-­analysis: melatonin for the treatment of primary sleep disorders. PLoS One 2013; 8:e63773.
10. Salanitro M, et al. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: a systematic review and meta-­analysis. Neurosci Biobehav Rev 2022; 139:104723.
11. Sheldon SH. Pro-­convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998; 351:1254.
12. Maestroni GJ. The immunoneuroendocrine role of melatonin. J Pineal Res 1993; 14:­1–­10.
13. Sutherland ER, et  al. Elevated serum melatonin is associated with the nocturnal worsening of asthma. J Allergy Clin Immunol 2003; 112:­513–­517.
14. Chase JE, et al. Melatonin: therapeutic use in sleep disorders. Ann Pharmacother 1997; 31:­1218–­1226.
15. Jan JE, et al. Melatonin treatment of sleep-­wake cycle disorders in children and adolescents. Dev Med Child Neurol 1999; 41:­491–­500.
16. Coppola G, et al. Melatonin in wake-­sleep disorders in children, adolescents and young adults with mental retardation with or without ­epilepsy: a double-­blind, cross-­over, placebo-­controlled trial. Brain Dev 2004; 26:­373–­376.
17. Garstang J, et al. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006; 32:­585–­589.
18. Gringras P, et al. Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo ­controlled trial. BMJ 2012; 345:e6664.
19. Brigo F, et al. Melatonin as add-­on treatment for epilepsy. Cochrane Database Syst Rev 2016; 2016:CD006967.
20. Malow BA, et al. Sleep, growth, and puberty after 2 years of prolonged-­release melatonin in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 2012; 60:­252–­261.e3.